Immuneering Corp [NASDAQ: IMRX] gained 32.64% on the last trading session, reaching $3.21 price per share at the time.
If compared to the average trading volume of 5.64M shares, IMRX reached a trading volume of 25014838 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Immuneering Corp [IMRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMRX shares is $11.21 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMRX stock is a recommendation set at 1.57. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Immuneering Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 15, 2024. The new note on the price target was released on March 15, 2024, representing the official price target for Immuneering Corp stock. Previously, the target price had yet another drop from $16 to $3, while Jefferies kept a Hold rating on IMRX stock.
The Average True Range (ATR) for Immuneering Corp is set at 0.41 The Price to Book ratio for the last quarter was 1.44, with the Price to Cash per share for the same quarter was set at 2.01.
Trading performance analysis for IMRX stock
Immuneering Corp [IMRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 58.91. With this latest performance, IMRX shares gained by 186.61% in over the last four-week period, additionally plugging by 17.58% over the last 6 months – not to mention a drop of -59.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IMRX stock in for the last two-week period is set at 77.39, with the RSI for the last a single of trading hit 78.94, and the three-weeks RSI is set at 75.07 for Immuneering Corp [IMRX]. The present Moving Average for the last 50 days of trading for this stock 1.34, while it was recorded at 2.71 for the last single week of trading, and 3.28 for the last 200 days.
Immuneering Corp [IMRX]: A deeper dive into fundamental analysis
Immuneering Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.39 and a Current Ratio set at 9.39.
Immuneering Corp [IMRX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Immuneering Corp posted -0.43/share EPS, while the average EPS was predicted by analysts to be reported at -0.49/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.06. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IMRX.
An analysis of Institutional ownership at Immuneering Corp [IMRX]
There are presently around $32.51%, or 45.90%% of IMRX stock, in the hands of institutional investors. The top three institutional holders of IMRX stocks are: CITADEL ADVISORS LLC with ownership of 1.88 million shares, which is approximately 6.4083%. VANGUARD GROUP INC, holding 1.07 million shares of the stock with an approximate value of $$1.37 million in IMRX stocks shares; and VANGUARD GROUP INC, currently with $$1.22 million in IMRX stock with ownership which is approximately 3.2455%.
